Because metastasis is a very significant factor in the clinical prognosis of patients and MCRS1 overexpression was observed in almost all NSCLC tissues, we speculate that therapies directed at preventing the EMT program mediated by MCRS1 might be a potential treatment for NSCLC, an avenue that is worthy of further study. Here, MCRS1 is linked to non-small cell lung carcinoma.